KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $40,293,000 | +82.4% | 224,083 | +5.2% | 0.04% | +66.7% |
| Q2 2017 | $22,089,000 | +47.7% | 213,063 | +11.9% | 0.02% | +40.0% |
| Q1 2017 | $14,951,000 | +92.3% | 190,474 | +9.9% | 0.02% | +66.7% |
| Q4 2016 | $7,773,000 | -15.4% | 173,342 | +5.4% | 0.01% | -18.2% |
| Q3 2016 | $9,187,000 | +21.3% | 164,448 | +8.6% | 0.01% | +22.2% |
| Q2 2016 | $7,572,000 | +20.7% | 151,428 | +10.8% | 0.01% | +12.5% |
| Q1 2016 | $6,273,000 | -12.7% | 136,626 | +17.2% | 0.01% | -20.0% |
| Q4 2015 | $7,183,000 | +25.6% | 116,557 | +13.4% | 0.01% | +25.0% |
| Q3 2015 | $5,721,000 | +53.2% | 102,743 | +67.7% | 0.01% | +60.0% |
| Q2 2015 | $3,735,000 | +106.8% | 61,248 | +95.7% | 0.01% | +66.7% |
| Q1 2015 | $1,806,000 | +16.5% | 31,302 | +16.5% | 0.00% | +50.0% |
| Q4 2014 | $1,550,000 | – | 26,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|